-
The authors enrolled women desiring postpartum use of a levonorgestrel-releasing intrauterine system in a randomized trial to determine whether use of the device would be higher when insertion occurred immediately postpartum rather than delaying placement to the standard postpartum visit.
-
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
-
The rate of sepsis with group b streptococcus (gbs) in neonates of colonized mothers is now less than 1%.
-
The authors randomized women with objectively validated heavy menstrual bleeding (mean menstrual blood loss [MBL] of 80 mL or more per cycle, confirmed using the alkaline hematin methodology during two pretreatment cycles) to treatment with oral tranexamic acid 3.9 g/d or placebo for up to 5 days per cycle for 6 menstrual cycles.
-
Nearly every reference source discussing the primary management of advanced ovarian cancer will highlight the role of surgical cytoreduction as an important first step in the care of this disease.
-
-
Specialty Surgical Center in Sparta, NJ, has used a three-part philosophy process to achieve significant savings, including a drastic reduction in overtime for preop nurses and a $10,000 savings in an equipment purchase.
-
Want to make more money next month? Look at your "variable costs" this month! Many professionals tend to overlook the amount of revenue that is generated by simply not spending money. The treasure chest lies within your own grasp.
-
This month, our special focus is on saving money and increasing revenue in outpatient surgery.
